A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand/cycloheximide-induced caspase activities during apoptosis initiation




TekijätHellwig CT, Kohler BF, Lehtivarjo AK, Dussmann H, Courtney MJ, Prehn JHM, Rehm M

KustantajaAMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

Julkaisuvuosi2008

JournalJournal of Biological Chemistry

Tietokannassa oleva lehden nimiJOURNAL OF BIOLOGICAL CHEMISTRY

Lehden akronyymiJ BIOL CHEM

Vuosikerta283

Numero31

Aloitussivu21676

Lopetussivu21685

Sivujen määrä10

ISSN0021-9258

eISSN1083-351X

DOIhttps://doi.org/10.1074/jbc.M802889200


Tiivistelmä
Employing fluorescence resonance energy transfer (FRET) imaging, we previously demonstrated that effector caspase activation is often an all-or-none response independent of drug choice or dose administered. We here investigated the signaling dynamics during apoptosis initiation via the tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptor pathway to investigate how variability in drug exposure can be translated into largely kinetically invariant cell death execution pathways. FRET-based microscopy demonstrated dose-dependent responses of caspase-8 activation and activity within individual living HeLa cells. Caspase-8 on average was activated 45-600 min after TRAIL/cycloheximide addition. Caspase-8 like activities persisted for 15-60 min before eventually inducing mitochondrial outer membrane permeabilization. Independent of the TRAIL concentrations used or the resulting caspase-8-like activities, mitochondrial outer membrane permeabilization was induced when 10% of the FRET substrate was cleaved. In contrast, in Bid-depleted cells, caspase-8-like activity persisted for hours without causing immediate cell death. Our findings provide detailed insight into the intracellular signaling kinetics during apoptosis initiation and describe a threshold mechanism controlling the induction of apoptosis execution.



Last updated on 2024-26-11 at 20:07